Is there an alternative treatment for patients intolerant to antiplatelet therapy if percutaneous left atrial appendage closure is considered?

INTRODUCTION: Left atrial appendage (LAA) closure has become of major interest for patients with atrial fibrillation intolerant to oral anticoagulation therapy (OAC). Patients with a contraindication to both OAC and antiplatelet therapy are not eligible for percutaneous LAA closure. We aimed to find...

Descripción completa

Detalles Bibliográficos
Autores principales: Akca, F., Verberkmoes, N. J., Verstraeten, S. E., van Laar, C., van Putte, B. P., van Straten, A. H. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bohn Stafleu van Loghum 2017
Materias:
Original Article - Design Study Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571603/
https://www.ncbi.nlm.nih.gov/pubmed/28429136
http://dx.doi.org/10.1007/s12471-017-0987-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571603/
https://www.ncbi.nlm.nih.gov/pubmed/28429136
http://dx.doi.org/10.1007/s12471-017-0987-y

Ejemplares similares